Search
PR-15
go.drugbank.com/drugs/DB06037InvestigationalPR-15 is a novel anti-platelet protein with the potential to treat arterial thrombosis occurring during acute coronary syndromes without the bleeding risk associated with existing agents.
Synonyms: RevaceptCeftazidime
go.drugbank.com/drugs/DB00438ApprovedInvestigationalBacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding proteins" (PBPs). β-lactam antibio...
Products: Fortum 2 g Pulver zur Herstellung einer Injektions- oder InfusionslösungSpesolimab
go.drugbank.com/drugs/DB15626ApprovedInvestigationalSpesolimab is an interleukin-36 (IL-36) receptor antagonist.
Categories: Interleukin-36 Receptor AntagonistSynonyms: Immunoglobulin G1, anti-(human interleukin 36 receptor) (humanized monoclonal BI 655130 gamma1-chain), disulfide with humanized monoclonal BI 655130 kappa-chain, dimerLB54640
go.drugbank.com/drugs/DB18331InvestigationalLB54640 is orally-administered small molecule agonist of the melanocortin 4 receptor.
Synonyms: Oral melanocortin 4 receptor agonist, Small molecule melanocortin 4 receptor agonistVancomycin
go.drugbank.com/drugs/DB00512ApprovedInvestigationalAntibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. As of January 29 2018, CutisPharma's Firvanq is the onl...
Products: Eberth 500 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung oder zur Herstellung einer Lösung zum Einnehmen, Eberth 1000 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung oder zur Herstellung einer Lösung zum EinnehmenFluorouracil
go.drugbank.com/drugs/DB00544ApprovedInvestigationalA pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.
Products: Fluorouracil Accord 50 mg/ml Injektions- oder InfusionslösungEpidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells
go.drugbank.com/drugs/DB18654InvestigationalSynonyms: Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells, Autologous Chimeric Antigen Receptor (CAR) Modified Recombinant T Cells Targeting EGFRvIIIEpirubicin
go.drugbank.com/drugs/DB00445ApprovedInvestigationalAn anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Products: Epirubicin Accord 2 mg/ml Lösung zur Injektion oder Infusion